热门资讯> 正文

MBX Biosciences GAAP每股收益为-0.71美元

2025-05-12 20:55

MBX Biosciences(MBX) 0

MBX Biosciences press release (NASDAQ:MBX): Q1 GAAP EPS of -$0.71.
Cash and Cash Equivalents and Marketable Securities: As of March 31, 2025, MBX Biosciences had cash, cash equivalents and marketable securities of $240.8 million.

More on MBX Biosciences

Historical earnings data for MBX Biosciences
Financial information for MBX Biosciences

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。